{"_id":"MONDO:0007187","_version":1,"ctd":{"chemical_related_to_disease":[{"chemical_name":"Antipsychotic Agents","direct_evidence":"therapeutic","mesh_chemical_id":"D014150","pubmed":"24803734","source":"CTD"},{"chemical_name":"HhAntag691","direct_evidence":"therapeutic","mesh_chemical_id":"C538724","pubmed":"25876211","source":"CTD"},{"cas_registry_number":"1406-16-2","chemical_name":"Vitamin D","direct_evidence":"therapeutic","mesh_chemical_id":"D014807","pubmed":"24803734","source":"CTD"}],"mesh":"D001478","pathway_related_to_disease":[{"inference_gene_symbol":"PTCH1","kegg_pathway_id":"hsa04024","pathway_name":"cAMP signaling pathway","source":"CTD"},{"inference_gene_symbol":["GLI2","PTCH1"],"kegg_pathway_id":"hsa04340","pathway_name":"Hedgehog signaling pathway","source":"CTD"},{"inference_gene_symbol":"PTCH1","kegg_pathway_id":"hsa04360","pathway_name":"Axon guidance","source":"CTD"},{"inference_gene_symbol":"GLI2","kegg_pathway_id":"hsa04390","pathway_name":"Hippo signaling pathway","source":"CTD"},{"inference_gene_symbol":["GLI2","PTCH1"],"kegg_pathway_id":"hsa05200","pathway_name":"Pathways in cancer","source":"CTD"},{"inference_gene_symbol":"PTCH1","kegg_pathway_id":"hsa05205","pathway_name":"Proteoglycans in cancer","source":"CTD"},{"inference_gene_symbol":["GLI2","PTCH1"],"kegg_pathway_id":"hsa05217","pathway_name":"Basal cell carcinoma","source":"CTD"},{"inference_gene_symbol":["GLI2","PTCH1"],"kegg_pathway_id":"hsa_M00678","pathway_name":"Hedgehog signaling","source":"CTD"},{"inference_gene_symbol":["GLI2","PTCH1","PTH"],"pathway_name":"Signal Transduction","react_pathway_id":"R-HSA-162582","source":"CTD"},{"inference_gene_symbol":["PTCH1","PTH"],"pathway_name":"Signaling by GPCR","react_pathway_id":"R-HSA-372790","source":"CTD"},{"inference_gene_symbol":["PTCH1","PTH"],"pathway_name":"Class B/2 (Secretin family receptors)","react_pathway_id":"R-HSA-373080","source":"CTD"},{"inference_gene_symbol":"PTH","pathway_name":"GPCR downstream signaling","react_pathway_id":"R-HSA-388396","source":"CTD"},{"inference_gene_symbol":"PTH","pathway_name":"G alpha (s) signalling events","react_pathway_id":"R-HSA-418555","source":"CTD"},{"inference_gene_symbol":["PTCH1","PTH"],"pathway_name":"GPCR ligand binding","react_pathway_id":"R-HSA-500792","source":"CTD"},{"inference_gene_symbol":["GLI2","PTCH1"],"pathway_name":"Signaling by Hedgehog","react_pathway_id":"R-HSA-5358351","source":"CTD"},{"inference_gene_symbol":"GLI2","pathway_name":"Degradation of GLI2 by the proteasome","react_pathway_id":"R-HSA-5610783","source":"CTD"},{"inference_gene_symbol":["GLI2","PTCH1"],"pathway_name":"Hedgehog 'off' state","react_pathway_id":"R-HSA-5610787","source":"CTD"},{"inference_gene_symbol":"PTCH1","pathway_name":"Ligand-receptor interactions","react_pathway_id":"R-HSA-5632681","source":"CTD"},{"inference_gene_symbol":["GLI2","PTCH1"],"pathway_name":"Hedgehog 'on' state","react_pathway_id":"R-HSA-5632684","source":"CTD"},{"inference_gene_symbol":"PTCH1","pathway_name":"Activation of SMO","react_pathway_id":"R-HSA-5635838","source":"CTD"},{"inference_gene_symbol":"GLI2","pathway_name":"GLI proteins bind promoters of Hh responsive genes to promote transcription","react_pathway_id":"R-HSA-5635851","source":"CTD"}]},"disease_ontology":{"_license":"https://github.com/DiseaseOntology/HumanDiseaseOntology/blob/master/DO_LICENSE.txt","ancestors":["DOID:2512","DOID:0050736","DOID:0050177","DOID:630","DOID:4","DOID:225","DOID:0050739"],"children":[],"def":"\"A nevoid basal cell carcinoma syndrome that has_material_basis_in heterozygous mutation in the PTCH1 gene on chromosome 9q22.\" [url:https\\://pubmed.ncbi.nlm.nih.gov/8658145/, url:https\\://www.omim.org/entry/109400]","descendants":[],"doid":"DOID:0070365","name":"nevoid basal cell carcinoma syndrome 1","parents":["DOID:0050736","DOID:2512"],"synonyms":{"exact":["basal cell nevus syndrome 1"]},"xrefs":{"mim":"109400"}},"mondo":{"ancestors":["MONDO:7770009","MONDO:0000001","MONDO:0045024","MONDO:7770007","MONDO:0021147","MONDO:0042489","MONDO:0020573","MONDO:7770008","MONDO:0019755","MONDO:0000429","MONDO:0005071","MONDO:0015356","MONDO:0021058","MONDO:0000426","MONDO:7770006","MONDO:0023370","MONDO:0700096","MONDO:0003847","MONDO:0100545","MONDO:0002254","MONDO:0042983"],"children":["MONDO:0958174","MONDO:0958189"],"curated_content_resource":{"https":["https://search.clinicalgenome.org/kb/conditions/MONDO:0007187"]},"definition":"A rare hereditary disorder due to autosomal dominant transmission with hamartosis characterized by multiple early-onset basal cell carcinoma (BCC), multiple jaw keratocysts and skeletal abnormalities. [Orphanet:377]","descendants":["MONDO:0958189","MONDO:0958174"],"disease_has_feature":{"mondo":["MONDO:0021313"]},"label":"nevoid basal cell carcinoma syndrome","mondo":"MONDO:0007187","parents":["MONDO:0000426","MONDO:0015356","MONDO:0019755","MONDO:0042983","MONDO:0100545"],"should_conform_to":{"http":["http://purl.obolibrary.org/obo/mondo/patterns/OMIM_phenotypic_series.yaml"]},"synonym":{"exact":["basal cell nevus syndrome","Gorlin syndrome","Gorlin-Goltz syndrome","multiple basal cell carcinomas","NBCCS","nevoid basal cell cancer syndrome","nevoid basal cell carcinoma syndrome"],"related":["BCNS"]},"xrefs":{"doid":["DOID:2512","DOID:0070365"],"gard":["0007166"],"icd11":["foundation:1012745138"],"meddra":["10062804"],"medgen":["2554"],"mesh":["D001478"],"nando":["2200828"],"ncit":["C2892"],"nord":["1507"],"omimps":["109400"],"orphanet":["377"],"sctid":["69408002"],"umls":["C0004779"]}},"umls":{"_license":"https://www.nlm.nih.gov/research/umls/knowledge_sources/metathesaurus/release/license_agreement.html","mesh":{"non-preferred":"D001478","preferred":"D001478"},"nci":{"non-preferred":"C2892","preferred":"C2892"},"snomed":{"non-preferred":["69408002","254704004","188145001"],"preferred":"69408002"},"umls":"C0004779"}}